Email this article 
The outcome of chemotherapeutic regimen by high-risk pre-B-cell protocol in ALL children
Abstract
Objective: The aim of this study was to investigate the outcome of chemotherapeutic regimen by high-risk pre-B-cell potocol in ALL children.
Methods: The cross-sectional study was conducted on 55 children who were treated with the Children Oncology Group (COG) protocol from September 2010 to February 2015 to evaluate the chemotherapeutic regimen results.
Results: There was a complete recovery rate of 76.4% during the first week after treatment. Three-year overall survival was 85.5% and five-year overall survival was 81%. Relapse rate after first remission was 20% and death after relapse was 50%. Thirty percent of total deaths were at the induction period. All of the deceased cases died due to sepsis.
Conclusion: Results showed that the survival rate increased. By choosing the COG protocol and by controlling infection in patients without considering the risk group we can improve survival rates.
Full Text:
PDFReferences
Belson, M., Kingsley, B., & Holmes, A. (2007). Risk factors for acute leukemia in children: A review. Environmental Health Perspectives, 115(1), 138–45.
Chali et al., (1985). Research Council Leukemia Trial. UKALL VII: A report to the council by the working party on leukemia in childhood. Arch Dis Child, 60, 1050–4.
Draper, G. J., Kroll, M. E., & Stiller, C. A. (1994). Childhood Cancer. Cancer Surv, 307, 493–517.
Eden, O. B., Lilleyman, J. S., Richards, S. M., Shaw, M. P., & Peto, J. (1991). Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the working party on leukaemia in childhood). British Journal of Haematology, 78(2), 187–96.
Farhangi, H., Badiei, Z., & Bani-Hashem, A. (2018). Evaluation of clinical symptoms and laboratory tests in patients with acute leukemia in Dr. Sheikh Hematology-Oncology Children’s Hospital. Presentation at 6th Meeting held 19–21 February 2010.
Friedmann, A. M., & Weinstein, H. J. (2000). The role of prognostic features in the treatment of Childhood acute lymphoblastic leukemia. The Oncologist, 2000 (4), 321–328.
Goudarzi, K. P., Eshghi, P., & Naderisorki, M. (2018). A comparison of two chemotherapeutic regimes in children with B-Cell Acute Lymphoblastic Leukemia. Journal of Comprehensive Pediatrics, 9(4), e64153.
Greaves, M. F. (1997). Aetiology of acute leukaemia. The Lancet, 349(9048), 344–9.
Gurney, J. G., Davis, S., Severson, R. K., Fang, J. Y., Ross, J. A., & Robison, L. L. (1996). Trends in cancer incidence among children in the US. Cancer, 78(3), 532–41.
Hashemi, A., Manochehri, N. M., Eslami, Z., Bahrami, A. A., Kheyr, A. M., Rafieian, M. (2009). Evaluation of prognostic and predictive factors in pediatric acute lymphoblatic leukemia patients admitted to Shahid Sadoughi Hospital, JSSU, 16(5), 14–19.
Hjalgrim, L. L., Rostgaard, K., Schmiegelow, K., Söderhäll, S., Kolmannskog, S., Vettenranta, K., Kristinsson, J., Clausen, N., Melbye, M., Hjalgrim, H., Gustafsson, G., & Mahoney, D. H. (1999). Acute lymphoblastic leukemia. In: McMillan, J. A., DeAngelis, C. D., Feigin, R. D. (Eds.), Oski’s Pediatrics Principles and Practice. 3rd ed. Lippincott Williams & Wilkins, 1999. 1493–1501.
Ishii, E., Eguchi, H., Matsuzaki, A., Koga, H., Yanai, F., Kuroda, H., Kawakami, K., Ayukawa H., Akiyoshi, K., Kamizono, J., & Tamai, Y. (2001). Outcome of acute lymphoblastic leukemia in children with AL90 regimen: Impact of response to treatment and sex difference on prognostic factors. Medical and Pediatric Oncology, 37(1), 10–9. 24
Kadan-Lottick, N. S., Ness, K. K., Bhatia, S., & Gurney, J. G. (2003). Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. JAMA, 290(15), 2008–14.
Kaiserová, E., Bubánska, E., Oravkinová, I., Šubová, Z., Kolenová, A., Foltinová, A.,& Čáp, J. (2011). Results of acute lymphoblastic leukemia treatment in children in the Slovak Republic. Magazine of European Medical Oncology, 4(3). 190.
Khazaei, Z., Goodarzi, E., Adinch, H. A., Morandi, Y. … Dehghani, L. (2019). Epidemiology, incidence and mortality of leukemia in children early infancy to 14 years of age in South Central Asia: A global ecological study. Journal of Comprehensive Pediatrics, 10(1), e82258. https://doi.org/10.5812/compreped.82258
Kim, A. S., Eastmond, D. A., Preston, R. J. (2006). Childhood acute lymphocytic leukemia and perspectives on risk assessment of early-life stage exposures. Mutation Research/Reviews in Mutation Research, 613(2–3), 138–60.
Mesdaghinia, A., Etemad, K., Gouya, M. M., Ramezani-Daryasari, R., Modiriyan, M., Partovipour, E., et al. (2013). Iranian Annual of National Cancer Registration Report, 2009–2010. Tehran: Ministry of Health and Medical Education, Health and Treatment Deputy.
Pedram, M., Fathi, A., & Hiradfar, A. A. (2010). Results of chemotherapy by UKCCSG protocolin children with acute lymphoblastic leukemia: Clinical characteristics and outcome. Pakistan Journal of Medical Sciences, 26(3), 562–6.
Podvin, D., Kuehn, C. M., Mueller, B. A., & Williams, M. (2006). Maternal and birth characteristics in relation to childhood leukaemia. Paediatric and Perinatal Epidemiology, 20(4), 312–22.
Shu, X.O., Han, D., Severson, R.K ., Chen, Z., Neglia, J. P., Reaman, G. H., Buckley, J. D., & Robison, L. L. (2002). Birth characteristics, maternal reproductive history, hormone use during pregnancy, and risk of childhood acute lymphocytic leukemia by immunophenotype (United States). Cancer Causes & Control, 13(1), 15–25.
Silverman, L. B., Gelber, R. D., Young, M. L., Dalton, V. K., Barr, R. D., & Sallan, S. E. (1999). Induction failure in acute lymphoblastic leukemia of childhood. Cancer, 85(6), 1395–404.
Stiller, C. A., & Eatock, E. M. (1999). Patterns of care and survival for children with acute lymphoblastic leukaemia diagnosed between 1980 and 1994. Archives of Disease in Childhood, 81(3), 202–8.
Winick, N. J., Carroll, W. L., & Hunger, S. P. (2004). Childhood leukemia—new advances and Challenges, New Eng J Med, 351(6), 601–603.
Refbacks
- There are currently no refbacks.
